BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23872542)

  • 1. Treatment of multicentric reticulohistiocytosis with tocilizumab.
    Pacheco-Tena C; Reyes-Cordero G; Ochoa-Albíztegui R; Ríos-Barrera V; González-Chávez SA
    J Clin Rheumatol; 2013 Aug; 19(5):272-6. PubMed ID: 23872542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory multicentric reticulohistiocytosis treated by infliximab: two cases.
    Sellam J; Deslandre CJ; Dubreuil F; Arfi S; Kahan A
    Clin Exp Rheumatol; 2005; 23(1):97-9. PubMed ID: 15789895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Vinblastine and Prednisone in Multicentric Reticulohistiocytosis With Onset in Infancy.
    Jha VK; Kumar R; Kunwar A; Singh A; Kumar M; Kumar M; Prasad R
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27199388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of multicentric reticulohistiocytosis with a combination of infliximab, prednisolone and methotrexate.
    Lee MW; Lee EY; Jeong YI; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2004; 84(6):478-9. PubMed ID: 15844643
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicentric reticulohistiocytosis associated with rheumatoid arthritis.
    Hoshina D; Shimizu T; Abe R; Murata J; Tanaka K; Shimizu H
    Rheumatol Int; 2005 Sep; 25(7):553-4. PubMed ID: 15765219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
    Asano T; Suzutani K; Watanabe A; Honda A; Mori N; Yashiro M; Sato S; Kobayashi H; Watanabe H; Hazama M; Kanno T; Suzuki E; Ishii S; Migita K
    Medicine (Baltimore); 2018 Aug; 97(33):e11449. PubMed ID: 30113451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy.
    Kalajian AH; Callen JP
    Arch Dermatol; 2008 Oct; 144(10):1360-6. PubMed ID: 18936400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged response of multicentric reticulohistiocytosis to low dose methotrexate.
    Rentsch JL; Martin EM; Harrison LC; Wicks IP
    J Rheumatol; 1998 May; 25(5):1012-5. PubMed ID: 9598911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentric reticulohistiocytosis with elevated cytokine serum levels.
    Bennàssar A; Mas A; Guilabert A; Julià M; Mascaró-Galy JM; Herrero C
    J Dermatol; 2011 Sep; 38(9):905-10. PubMed ID: 21658110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric reticulohistiocytosis masquerading as cutaneous connective tissue disease.
    Fronek L; Bindernagel R; Segars K; Miller R
    Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate.
    Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2013 Feb; 16(1):105-6. PubMed ID: 23441782
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple cutaneous reticulohistiocytosis].
    Loche F; Lucas F; Bayle-Lebey P; Bazex J
    Ann Dermatol Venereol; 2000 May; 127(5):507-9. PubMed ID: 10863183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric reticulohistiocytosis: a case report of an atypical presentation in a 2-year-old.
    Olson J; Mann JA; White K; Cartwright VW; Bauer J; Nolt D
    Pediatr Dermatol; 2015; 32(3):e70-3. PubMed ID: 25727569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Reticulohistiocytosis (Mrh): A Case Report On A Rare Destructive Arthritis.
    Bano S; Khursheed T; Bosan MK; Khurshid S
    J Ayub Med Coll Abbottabad; 2023; 35(2):316-319. PubMed ID: 37422829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric reticulohistiocytosis: a critical review.
    Selmi C; Greenspan A; Huntley A; Gershwin ME
    Curr Rheumatol Rep; 2015 Jun; 17(6):511. PubMed ID: 25900189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
    Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
    Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentric reticulohistiocytosis associated arthritis responding to anti-TNF and methotrexate.
    De Knop KJ; Aerts NE; Ebo DG; Van Offel JF; Stevens WJ; De Clerck LS
    Acta Clin Belg; 2011; 66(1):66-9. PubMed ID: 21485770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought.
    Fett N; Liu RH
    Dermatology; 2011; 222(2):102-8. PubMed ID: 21252485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980-2017).
    Sanchez-Alvarez C; Sandhu AS; Crowson CS; Wetter DA; McKenzie GA; Lehman JS; Makol A
    Rheumatology (Oxford); 2020 Aug; 59(8):1898-1905. PubMed ID: 31742640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate treatment of multicentric reticulohistiocytosis.
    Gourmelen O; Le Loët X; Fortier-Beaulieu M; Thomine E; Ledan G; Lauret P; Deshayes P
    J Rheumatol; 1991 Apr; 18(4):627-8. PubMed ID: 2066959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.